Disposition of 7543 shares by Amit Gupta of Cardlytics at 3.085 subject to Rule 16b-3
| CDLX Stock | USD 3.06 0.10 3.16% |
Slightly above 72% of Cardlytics' investor base is looking to short. The current sentiment regarding investing in Cardlytics stock implies that many traders are alarmed. Cardlytics' investing sentiment can be driven by a variety of factors including economic data, Cardlytics' earnings reports, geopolitical events, and overall market trends.
Cardlytics |
Filed transaction by Cardlytics Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Read at macroaxis.com
Cash Flow Correlation
Cardlytics' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cardlytics' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Cardlytics Fundamental Analysis
We analyze Cardlytics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cardlytics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cardlytics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Cardlytics is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Cardlytics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cardlytics stock to make a market-neutral strategy. Peer analysis of Cardlytics could also be used in its relative valuation, which is a method of valuing Cardlytics by comparing valuation metrics with similar companies.
Peers
Cardlytics Related Equities
| MCHX | Marchex | 1.00 | ||||
| OMC | Omnicom | 0.31 | ||||
| CRTO | Criteo Sa | 0.03 | ||||
| IAS | Integral | 0.00 | ||||
| IPG | Interpublic Group | 0.14 | ||||
| CTV | Innovid Corp | 0.32 | ||||
| DLX | Deluxe | 0.98 | ||||
| BOC | Boston Omaha | 1.29 | ||||
| EEX | Emerald Expositions | 2.81 | ||||
| ADV | Advantage Solutions | 2.94 | ||||
| QNST | QuinStreet | 3.19 | ||||
| CMPR | Cimpress | 5.25 |
Additional Tools for Cardlytics Stock Analysis
When running Cardlytics' price analysis, check to measure Cardlytics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardlytics is operating at the current time. Most of Cardlytics' value examination focuses on studying past and present price action to predict the probability of Cardlytics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardlytics' price. Additionally, you may evaluate how the addition of Cardlytics to your portfolios can decrease your overall portfolio volatility.